MedElevator Войти в исследования
← Поиск публикаций

DOI 10.22038/ijorl.2023.71955.3444

Медицинская библиотека · Iranian journal of otorhinolaryngology · 2023

Omega-3 Adjunctive Therapy in Idiopathic SSNHL: A Randomised, Triple-Blind, Placebo-Controlled Trial.

Rahmaty Benyamin, Aghazadeh Kayvan, Dabiri Sasan, Motasaddi Zarandy Masoud, Kouhi Ali, Yazdani Nasrin, Erfanian Reza, Tajdini Ardavan, Sohrabpour Saeed, Safi Fatemeh, Shamsa Reza, Ravand Hamideh, Jafari Neda

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Idiopathic Sudden Sensorineural Hearing Loss as a subset of sensorineural hearing loss will be confirmed by a progressive hearing loss of at least 30 dB at three contiguous frequencies over 72 hours or less. A sudden or abrupt hearing loss correlates with the time course, and a vascular event is presumptive aetiology. There is an inverse association between Omega-3 consumption and hearing loss. This study aimed to evaluate the efficacy of Omega-3 adjunctive therapy in Idiopathic Sudden Sensorineural Hearing Loss by audiometric assessments.

MATERIALS AND

METHODS

In this randomised, triple-blind, placebo-controlled trial, all participants aged 18-70 with a history of sudden deafness (within 12 hours and ≤ 30 days) were eligible for enrollment. They were included if audiology diagnostic tests confirmed the SSNHL. Ultimately, they were randomised to the Omega-3 group and the placebo group.

RESULTS

Thirty-three patients were randomly allocated to the Omega-3 group and thirty-two to the placebo group. Vertigo (32.3% of all patients) and underlying conditions had significant relationships with complete response (C.R.)-final hearing level ≤of 25 dB in pure-tone average (P < 0.05). There was no significant difference between both groups before and after treatment. Although it was not statistically significant, patients in the Omega-3 group had faster recovery than placebo.

CONCLUSIONS

Omega-3 adjunctive therapy did not have a therapeutic effect on SSNHL patients. Moreover, C.R. happened in half the patients. Vertigo and underlying conditions considerably worsen the recovery from SSNHL.

Для цитирования: Rahmaty Benyamin, Aghazadeh Kayvan, Dabiri Sasan, Motasaddi Zarandy Masoud, Kouhi Ali, Yazdani Nasrin, Erfanian Reza, Tajdini Ardavan, Sohrabpour Saeed, Safi Fatemeh, Shamsa Reza, Ravand Hamideh, Jafari Neda. Omega-3 Adjunctive Therapy in Idiopathic SSNHL: A Randomised, Triple-Blind, Placebo-Controlled Trial.. Iranian journal of otorhinolaryngology. 2023. DOI: 10.22038/ijorl.2023.71955.3444.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.